ZA905841B - Spirocyclic antipsychotic agents - Google Patents

Spirocyclic antipsychotic agents

Info

Publication number
ZA905841B
ZA905841B ZA905841A ZA905841A ZA905841B ZA 905841 B ZA905841 B ZA 905841B ZA 905841 A ZA905841 A ZA 905841A ZA 905841 A ZA905841 A ZA 905841A ZA 905841 B ZA905841 B ZA 905841B
Authority
ZA
South Africa
Prior art keywords
spirocyclic
antipsychotic agents
spiro
piperidine
dihydronaphthalene
Prior art date
Application number
ZA905841A
Other languages
English (en)
Inventor
David Charles Billington
Charles Billington David
Mark Stuart Chambers
Stuart Chambers Mark
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of ZA905841B publication Critical patent/ZA905841B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA905841A 1989-07-26 1990-07-25 Spirocyclic antipsychotic agents ZA905841B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917069A GB8917069D0 (en) 1989-07-26 1989-07-26 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA905841B true ZA905841B (en) 1991-06-26

Family

ID=10660644

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA905841A ZA905841B (en) 1989-07-26 1990-07-25 Spirocyclic antipsychotic agents

Country Status (17)

Country Link
EP (1) EP0414289B1 (xx)
JP (1) JPH03184959A (xx)
KR (1) KR910002444A (xx)
AT (1) ATE101854T1 (xx)
AU (1) AU628612B2 (xx)
CA (1) CA2021736A1 (xx)
DE (1) DE69006799T2 (xx)
DK (1) DK0414289T3 (xx)
ES (1) ES2062303T3 (xx)
FI (1) FI903728A0 (xx)
GB (1) GB8917069D0 (xx)
IE (1) IE902706A1 (xx)
IL (1) IL95124A0 (xx)
NO (1) NO903315L (xx)
NZ (1) NZ234557A (xx)
PT (1) PT94806A (xx)
ZA (1) ZA905841B (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445974A3 (en) * 1990-03-05 1992-04-29 Merck Sharp & Dohme Ltd. Spirocyclic antipsychotic agents
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
CA2143117A1 (en) * 1992-10-07 1994-04-14 Ben E. Evans Tocolytic oxytocin receptor antagonists
US5670509A (en) * 1993-09-27 1997-09-23 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
AU2223495A (en) * 1994-04-15 1995-11-10 Yamanouchi Pharmaceutical Co., Ltd. Spiro compound and medicinal composition thereof
SK17512001A3 (sk) * 1999-06-07 2002-11-06 Warner-Lambert Company Tricyklické analgetiká
US7045527B2 (en) 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
BRPI0508098A (pt) 2004-02-27 2007-07-17 Amgen Inc compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
JP2008510728A (ja) 2004-08-19 2008-04-10 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
US7786141B2 (en) 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
AU2005276590B2 (en) 2004-08-27 2011-05-19 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
KR20070046194A (ko) 2004-08-27 2007-05-02 라보라토리오스 델 드라. 에스테브.에스.에이. 시그마 수용체 저해제
EP1634873A1 (en) 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
DK1781618T3 (da) 2004-08-27 2012-10-29 Esteve Labor Dr Sigma-receptorinhibitorer
WO2006058303A2 (en) 2004-11-29 2006-06-01 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP1924546A1 (en) 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
WO2007076070A2 (en) 2005-12-22 2007-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
KR20080094964A (ko) * 2006-02-22 2008-10-27 버텍스 파마슈티칼스 인코포레이티드 무스카린성 수용체의 조절제
KR20080098070A (ko) 2006-02-22 2008-11-06 버텍스 파마슈티칼스 인코포레이티드 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘
EP1829875A1 (en) 2006-03-01 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
JP2009528315A (ja) 2006-03-01 2009-08-06 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ シグマ受容体阻害剤としてのピラゾール誘導体
EP1829866A1 (en) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
EP1829867A1 (en) 2006-03-03 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Imidazole compounds having pharmaceutical activity towards the sigma receptor
JP2009542670A (ja) 2006-06-29 2009-12-03 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体の調節剤
AU2007284548A1 (en) 2006-08-15 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
JP2010501561A (ja) 2006-08-18 2010-01-21 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体の調節剤
US7714008B2 (en) 2006-09-07 2010-05-11 Amgen Inc. Heterocyclic GPR40 modulators
EP2061760A1 (en) 2006-09-07 2009-05-27 Amgen, Inc Benzo-fused compounds for use in treating metabolic disorders
WO2008130514A1 (en) 2007-04-16 2008-10-30 Amgen Inc. Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
US7973162B2 (en) 2007-10-03 2011-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
WO2009048527A1 (en) 2007-10-10 2009-04-16 Amgen Inc. Substituted biphenyl gpr40 modulators
WO2009111056A1 (en) 2008-03-06 2009-09-11 Amgen Inc. Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
US8748462B2 (en) 2008-10-15 2014-06-10 Amgen Inc. Spirocyclic GPR40 modulators
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2395003A1 (en) 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazole compounds as sigma receptor inhibitors
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
EP3082782A1 (en) 2013-12-17 2016-10-26 Laboratorios Del. Dr. Esteve, S.A. SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides

Also Published As

Publication number Publication date
NZ234557A (en) 1992-12-23
FI903728A0 (fi) 1990-07-25
JPH03184959A (ja) 1991-08-12
KR910002444A (ko) 1991-02-25
DE69006799T2 (de) 1994-08-11
EP0414289B1 (en) 1994-02-23
ATE101854T1 (de) 1994-03-15
NO903315L (no) 1991-01-28
PT94806A (pt) 1991-03-20
DK0414289T3 (da) 1994-04-11
ES2062303T3 (es) 1994-12-16
EP0414289A1 (en) 1991-02-27
GB8917069D0 (en) 1989-09-13
DE69006799D1 (de) 1994-03-31
AU628612B2 (en) 1992-09-17
CA2021736A1 (en) 1991-01-27
AU5984490A (en) 1991-01-31
NO903315D0 (no) 1990-07-25
IL95124A0 (en) 1991-06-10
IE902706A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
ZA905841B (en) Spirocyclic antipsychotic agents
GR3023817T3 (en) BIS-STAUROSPORINE AND K-252a DERIVATIVES.
GR3005447T3 (xx)
DE69203928T2 (de) Fahrzeugmontageverfahren und Fahrzeugkarosserie.
NZ234679A (en) 4-phosphonomethyl-2-hydroxy-2-oxo-1,4,2-oxazaphosphorinane n-oxide and salts thereof
DE3779290D1 (de) Maschine zum formen von konus und flansch an spruehdosen und dergleichen.
GB8914928D0 (en) Vorrichtung zum erkennen und verfolgen von objekten
DE58900363D1 (de) Vorrichtung zum aufrichten und aufreihen von formteilen.
EP0410535A3 (en) Octahydrobenzisoquinoline derivatives as antipsychotic agents
GR3007304T3 (xx)
DE69000853D1 (de) Semi-aktive aufhaengungsvorrichtung und mit dieser vorrichtung ausgestattetes kraftfahrzeug.
ZA937153B (en) 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz [cd]indoles for treating motion sickness and vomiting.
DE3866057D1 (en) Erythromycin-a-derivate, modifiziert in position-c-12.
TW197422B (xx)
ZA937154B (en) 6-Heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd] indoles for treating motion sickness and vomiting
GR3015469T3 (en) 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS.
YU135289A (en) 5,6,7,8-tetrahydro-4-h-izoxazolo/4,5-d/-azepine-3-ol derivatives
DE68903360D1 (de) Hydropneumatische aufhaengungsvorrichtung und mit dieser vorrichtung ausgestattetes fahrzeug.
GR3005838T3 (xx)
EP0637960A4 (en) INDOLIZINO 1,2-b] SUBSTITUTED QUINOLINONES.
IE894162L (en) 1-azabicyclo £2.2.1| heptane derivative
CS12288A1 (en) 5,6-bis/3-alkoxycarbonyl-1-1-2-thioureido/-benzimidazoles
PH31179A (en) 1,3 Substituted cycloalkenes and cycloalkanes as central nervous system agents.
OA09831A (en) "Safety device for tyres".
IE882864L (en) Glaucoma treatment